CCL19 Recombinant Antibody, RBITC Conjugated, Rabbit

Produktübersicht

• Artikelname: CCL19 Recombinant Antibody, RBITC Conjugated, Rabbit
• Artikelnummer: BSS-BSM-61386R-RBITC
• Hersteller Artikelnummer: bsm-61386R-RBITC
• Alternativnummer: BSS-BSM-61386R-RBITC-100
• Hersteller: Bioss
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: FC, WB
• Spezies Reaktivität: Human
• Konjugation: RBITC
• Alternative Synonym: CCL19, CK beta 11, CKb11, ELC, Exodus3, MIP3 beta, MIP3B, SCYA19.

Produktbeschreibung

May play a role not only in inflammatory and immunological responses but also in normal lymphocyte recirculation and homing. May play an important role in trafficking of T-cells in thymus, and T-cell and B-cell migration to secondary lymphoid organs. Binds to chemokine receptor CCR7. Recombinant CCL19 shows potent chemotactic activity for T-cells and B-cells but not for granulocytes and monocytes. Binds to atypical chemokine receptor ACKR4 and mediates the recruitment of beta-arrestin (ARRB1/2) to ACKR4.

Produkteigenschaften

• Klonalität: Recombinant
• Konzentration: Lot dependent
• NCBI: 6363
• UniProt: Q99731
• Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
• Quelle: KLH conjugated synthetic peptide derived from human CCL19
• Target-Kategorie: CCL19

Anwendungsbeschreibung

• Application Verdünnung: WB(1:300-5000), FCM(1ug/Test)